21.03.2013 Views

Exploring the Unknown - NASA's History Office

Exploring the Unknown - NASA's History Office

Exploring the Unknown - NASA's History Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

this study could exercise <strong>the</strong> system in part, or in its entirety, thus supporting <strong>the</strong> concept<br />

of a true multiproduct system.<br />

While this study was done to assess <strong>the</strong> commercial feasibility of manufacturing pharmaceutical<br />

products in space, it serves as a model for those who wish to consider o<strong>the</strong>r<br />

processes or products in <strong>the</strong> same environment. The use of <strong>the</strong> mass balance analytical<br />

concept forces a delineation of what must be accomplished in <strong>the</strong> process for each product<br />

in a stepwise fashion. The calculated quantities of materials at each step will quickly<br />

determine if <strong>the</strong> process is feasible with current technology, where <strong>the</strong> areas of information<br />

must be obtained to fill in <strong>the</strong> gaps, and anticipated recurring transportation costs to<br />

haul <strong>the</strong> material to and from space. While it does not define <strong>the</strong> total cost of <strong>the</strong> system,<br />

it does give <strong>the</strong> prospective manufacturer and NASA a general idea of <strong>the</strong> size, power and<br />

weight of <strong>the</strong> processing equipment as well as <strong>the</strong> extent and type of storage requirements.<br />

The length of <strong>the</strong> missions will be defined to determine economic feasibility. This will<br />

have to be interwoven with <strong>the</strong> NASA program and schedules to determine if, and when,<br />

a vehicle capability will be available to support such a manufacturing facility. Legal and<br />

regulatory considerations will also have to be defined.<br />

Recommendations for future work are presented. . . . It is recommended that drug<br />

firm involvement be continued and encouraged both in ground research and product<br />

evaluation. Because of companies’ sensitivity about government interference and disclosure<br />

of trade secrets, each company should be dealt with on an individual basis with some<br />

o<strong>the</strong>r private firm serving as a buffer or interface between <strong>the</strong> individual companies and<br />

<strong>the</strong> government. Heavier involvement through evolutionary processes will probably lead<br />

to direct participation in space activities. Such participation will logically require a user<br />

development laboratory for <strong>the</strong>se companies’ product developments.<br />

Document III-24<br />

Document title: James Beggs, Administrator, NASA, to William Clark, Assistant to <strong>the</strong><br />

President for National Security Affairs, August 26, 1983, with attached: John F. Yardley,<br />

President, McDonnell Douglas Astronautics Company, to James Beggs, Administrator,<br />

NASA, August 23, 1983.<br />

Source: Ronald W. Reagan Library, Sima, California.<br />

After an August 3, 1983, meeting with President Ronald Reagan, John Yardley, <strong>the</strong> president of<br />

McDonnell Douglas Astronautics Company, offered to be <strong>the</strong> first commercial user of a NASA space<br />

station. In <strong>the</strong> interim, before <strong>the</strong> station became operational, Yardley proposed manufacturing by<br />

using free-flying spacecraft. The business plan revolved around <strong>the</strong> successful results of experiments<br />

in drug production aboard <strong>the</strong> Space Shuttle.<br />

Honorable William Clark<br />

Assistant to <strong>the</strong> President for<br />

National Security Affairs<br />

The White House<br />

Washington, D.C. 20506<br />

EXPLORING THE UNKNOWN 539<br />

August 26, 1983<br />

Dear Bill:<br />

I just received <strong>the</strong> [handwritten underlining] enclosed letter from John Yardley of<br />

McDonnell Douglas. [“This is our” crossed out by hand and replaced by handwritten “re:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!